KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Amortization of Deferred Charges (2018 - 2025)

Historic Amortization of Deferred Charges for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $318000.0.

  • ClearPoint Neuro's Amortization of Deferred Charges rose 134545.45% to $318000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $490000.0, marking a year-over-year increase of 64242.42%. This contributed to the annual value of $51000.0 for FY2024, which is 1052.63% down from last year.
  • As of Q3 2025, ClearPoint Neuro's Amortization of Deferred Charges stood at $318000.0, which was up 134545.45% from $172000.0 recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Amortization of Deferred Charges peaked at $318000.0 during Q3 2025, and registered a low of $13000.0 during Q1 2022.
  • In the last 5 years, ClearPoint Neuro's Amortization of Deferred Charges had a median value of $15000.0 in 2023 and averaged $57529.4.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first plummeted by 8805.59% in 2021, then soared by 134545.45% in 2025.
  • ClearPoint Neuro's Amortization of Deferred Charges (Quarter) stood at $40000.0 in 2021, then crashed by 65.0% to $14000.0 in 2022, then grew by 7.14% to $15000.0 in 2023, then surged by 46.67% to $22000.0 in 2024, then skyrocketed by 1345.45% to $318000.0 in 2025.
  • Its last three reported values are $318000.0 in Q3 2025, $172000.0 for Q2 2025, and $22000.0 during Q3 2024.